Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 1, 2005, Pages 156-161

  Reechaipichitkul, Wipa ^a   Lulitanond, Viraphong ^a   Tantiwong, Puntip ^a   Saelee, Ratchanee ^a   Pisprasert, Veeradej ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD ANALYSIS; BURKHOLDERIA PSEUDOMALLEI; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; FEMALE; FREQUENCY ANALYSIS; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PNEUMOTHORAX; PRACTICE GUIDELINE; SEPTIC SHOCK; SEROLOGY; SHOCK; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; THAILAND; TREATMENT OUTCOME;

EID: 17744375435     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bartlett JG, Dowell SF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811-38.
2. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-24.
3. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101: 1005-12.
4. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995; 50: 543-7.
5. Boonsawat W, Boonma P, Tangdajahiran T, et al. Community-acquired pneumonia in adults at Srinagarind Hospital. J Med Assoc Thai 1990; 73: 345-52.
6. Brown RB, Iannini P, Gross P, Kunkel M. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Chest 2003; 123: 1503-11.
7. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 1998; 158: 1102-8.
8. Ewig S, Torres A. Severe community acquired pneumonia. Clin Chest Med 1999; 20: 575-87.
9. File Jr TM, Tan JS. Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia. Curr Opin Pulm Med 1997; 3: 89-97.
10. File Jr TM, Tan JS. International guidelines for the treatment of community-acquired pneumonia in adults : the role of macrolides. Drugs 2003; 63: 181-205.
11. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1995; 274: 134-41.
12. Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized eldery patients with pneumonia. Arch Intern Med 1999; 159: 2562-72.
13. Kauppinen M, Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 1995; 21 (suppl 3): S244-52.
14. Liam CK, Lim KH, Wong CM. Community-acquired pneumonia in patients requiring hospitalization. Respirology 2001; 6: 259-64.
15. Lieberman D, Schlaeffer F, Boldur J, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-84.
16. Mandell L. Community-acquired pneumonia: etiology, epidemiology, and treatment. Chest 1995; 108 (suppl): S35-42.
17. Meehan TP, Fine MJ, Kruholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-4.
18. Ministry of Public Health, Thailand. Diseases under surveillance. Wkly Epidemiol Surveill Rep. 1998; 29:93-100, 257-64.
19. Miyashita N, Fukano H, Okimoto N, et al. Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 2002; 121: 1776-81.
20. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
21. Plouffe JF. Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis 2000; 31 (suppl 2): S35-9.
22. Salkind AR, Cuddy PG, Foxworth JW. Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis. Ann Pharmacother 2002; 36: 1938-43.
23. Stahl JE, Barza M, DesJardin J, et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999; 159: 2576-80.
24. Tan YK, Khoo KL, Clin SP, Ong YY. Aetiology and outcome of severe community-acquired pneumonia n Singapore. Eur Respir J 1998; 12: 113-5.
25. Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-acquired pneumonia in Southeast Asia: the microbial differences between ambulatory and hospitalized patients. Chest 2003; 123: 1512-9.